During his time in industry, Paul led teams at Takeda and Nycomed responsible for developing launch pricing and reimbursement strategies, optimising price of in-market products and providing input into R&D for pipeline products.
Paul is a visiting lecturer at Grenoble Business school and frequently presents on cutting edge pricing and market access topics at major conferences.
Graham’s industry experience includes GSK, start-up biotech and Ferring pharmaceuticals. During his time at Ferring, Graham was Global Head of Market Access and Pricing, taking responsibility for pharmaceutical & diagnostic products and product launches. Graham’s consultancy experience includes both IMS consulting (previously Cambridge Pharma) and Adelphi Values.
As a pricing and market access expert, Graham regularly speaks at conferences and is a guest lecturer at Grenoble Business school.
Our Team Members
Prior to joining Remap Consulting, Charlie worked at Blueprint Partnership and InterPhase Consult, the strategy consulting arm of Ashfield Healthcare Communications.
Since making the switch to consultancy Hannah has held consultant roles with responsibility for delivering HTA submissions, real-world evidence, value demonstration and health economics projects. Hannah has experience across multiple therapy areas including rare diseases, asthma, diabetes and oncology. She has also carried out projects in biosimilars.
Hannah has a Master of Pharmacy degree from the University of Nottingham and completed her pre-registration training with University Hospitals of Leicester and AstraZeneca.
Prior to joining Remap Consulting, Sarah gained experience at Adelphi Values and AstraZeneca providing support for a variety of projects across various therapy areas.
Fatima’s scientific background and business acumen has also enabled her to successfully complete disease opportunity assessments and develop strong value propositions for top pharmaceutical clients.
Prior to joining Remap Consulting, Fatima worked at McCann Health on a range of pricing and market access projects.
Prior to joining Remap Consulting, Mike was a Medical Affairs Operations Executive at ViiV Healthcare. He has significant experience in project management, from projects involving clinical data tools to process improvement initiatives, as well as experience in the delivery of training of pricing and reimbursement systems across the world.
Mike has been involved on projects covering a diverse range of healthcare topics, including precision medicine, rare diseases and the treatment of HIV.
Mike has a BSc in Pharmacology from the University of Leeds.
Prior to joining Remap Consulting, Charlotte worked within Astrazeneca in international marketing functions across a range of therapy areas and brand teams.
Prior to joining Remap Consulting, Edward was an intern consultant at IP Pragmatics, where he gained experience of market research and patent landscape analysis, while assisting in the commercialisation of new technologies within the biosciences. Edward has experience of working within a number of research areas, including genetics, medical devices and plant sciences.
Edward has a BSc in Genetics from the University of Liverpool.
Powerpoint and Word are Emily’s specialist areas of expertise with an advanced in-depth knowledge of editing, formatting and design. Emily is a proactive & enthusiastic individual with natural creative flair and a ‘can do’ attitude. Prior to joining Remap Consulting, Emily worked at AstraZeneca and Adelphi International Research providing support for a variety of projects across various therapy areas.
Andreas is regularly invited as an expert speaker on conferences around Market Access and as a member of advisory board panels to the pharmaceutical industry. He is the founder of the “European Journal of Health Economics”.
Andreas and Remap Consulting have collaborated on a wide range of pricing and market access projects, including payer advisory boards and payer scientific advice meetings.
Ben has worked extensively in Latin America, Asia-Pacific, Middle East & Africa and Eastern European countries, with a particular focus on the BRICMT markets and high-growth developing economies worldwide. He has worked in all major therapy areas, including oncology, diabetes, respiratory medicine and innovative vaccines.
Fluent in Spanish and Portuguese, Ben holds a Master’s degree from Oxford University.